MESA LABORATORIES INC /CO/

For the period ended Jun 30, 2026. Filed Aug 10, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 10, 2026

MLAB$127.82-0.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

M****esa Laboratories, Inc.**

Condensed Consolidated Balance Sheets

(in thousands, except share amounts)

	June 30,	March 31,
	2026	2026
ASSETS
Current assets:
Cash and cash equivalents	$30,695	$26,928
Accounts receivable, less allowance for credit losses of $1,852 and $2,569, respectively	34,409	44,099
Inventories	27,229	26,373
Prepaid expenses and other current assets	10,515	8,868
Total current assets	102,848	106,268
Noncurrent assets:
Property, plant and equipment, net of accumulated depreciation of $31,113 and $30,115, respectively	30,088	30,613
Deferred tax asset	1,488	1,501
Other assets	20,360	19,155
Customer relationships, net	59,594	63,211
Other intangibles, net	18,808	20,136
Goodwill	186,038	186,863
Total assets	$419,224	$427,747
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$7,459	$4,928
Accrued payroll and benefits	13,179	19,006
Unearned revenue	14,523	14,723
Other accrued expenses	16,536	17,616
Term loan, current portion	5,625	5,625
Total current liabilities	57,322	61,898
Noncurrent liabilities:
Deferred tax liability	20,046	20,085
Non-current operating lease liabilities	15,852	13,662
Term loan, noncurrent portion, net of debt issuance costs	59,994	61,357
Revolving line of credit	77,250	84,500
Total liabilities	230,464	241,502
Stockholders’ equity:
Common stock, no par value; authorized 25,000,000 shares; issued and outstanding, 5,595,780 and 5,524,931 shares, respectively	376,749	375,348
(Accumulated deficit)	(183,801)	(185,747)
Accumulated other comprehensive (loss)	(4,188)	(3,356)
Total stockholders’ equity	188,760	186,245
Total liabilities and stockholders’ equity	$419,224	$427,747

See accompanying notes to Condensed Consolidated Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.